Loading…
Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region
Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and exa...
Saved in:
Published in: | AIDS and behavior 2024-11, Vol.28 (11), p.3629-3642 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c256t-fcd16b1583d24f6f7031f039a7f8d217ad4f4e43f29fdf515f5c6c213664160d3 |
container_end_page | 3642 |
container_issue | 11 |
container_start_page | 3629 |
container_title | AIDS and behavior |
container_volume | 28 |
creator | Bailey, Katie Abramovitz, Daniela Rangel, Gudelia Harvey-Vera, Alicia Vera, Carlos F. Patterson, Thomas L. Sánchez-Lira, Jaime Arredondo Davidson, Peter J. Garfein, Richard S. Smith, Laramie R. Pitpitan, Eileen V. Goldenberg, Shira M. Strathdee, Steffanie A. |
description | Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. PWID were recruited via street outreach for a longitudinal cohort study from October 2020–September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE score levels (low, medium, high) using ordinal logistic regression. Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to change the risk environment. |
doi_str_mv | 10.1007/s10461-024-04433-9 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3085116144</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3085116144</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-fcd16b1583d24f6f7031f039a7f8d217ad4f4e43f29fdf515f5c6c213664160d3</originalsourceid><addsrcrecordid>eNp9kUuOEzEQhi0EYobABVggS2zYNJTbj-5ehsxAIo0EIsOwtDx-dBx17GB3g7LjCogbchIMCSCxYOWS_NVfpfoQekzgOQFoXmQCTJAKalYBY5RW3R10TnhDK1pzdrfU0EHVEMHP0IOctwDQiaa7j85oBwJa2pyjr2vlLF6FrdWjjwGv7eCqS-e8VvqAfcbznKP2arQGf_bjBi8XN1gFg5ermwKnuI_Zj_6THw94vouhx29t3A8Wf9jEUyy-SFOfsQ943Fi8VgFfeNvH71--XfvtpILCL2MyNuF3ti8rPET3nBqyfXR6Z-j9q8vrxbK6evN6tZhfVbrmYqycNkTcEt5SUzMnXAOUOKCdalxratIowxyzjLq6c8Zxwh3XQteECsGIAENn6Nkxd5_ix8nmUe581nYYVLBxypJCywkRpFx2hp7-g27jlELZTtKCgKC8awtVHymdYs7JOrlPfqfSQRKQP4XJozBZhMlfwmRXmp6coqfbnTV_Wn4bKgA9Arl8hd6mv7P_E_sDk_agyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3116063598</pqid></control><display><type>article</type><title>Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region</title><source>Springer Nature</source><source>Sociological Abstracts</source><creator>Bailey, Katie ; Abramovitz, Daniela ; Rangel, Gudelia ; Harvey-Vera, Alicia ; Vera, Carlos F. ; Patterson, Thomas L. ; Sánchez-Lira, Jaime Arredondo ; Davidson, Peter J. ; Garfein, Richard S. ; Smith, Laramie R. ; Pitpitan, Eileen V. ; Goldenberg, Shira M. ; Strathdee, Steffanie A.</creator><creatorcontrib>Bailey, Katie ; Abramovitz, Daniela ; Rangel, Gudelia ; Harvey-Vera, Alicia ; Vera, Carlos F. ; Patterson, Thomas L. ; Sánchez-Lira, Jaime Arredondo ; Davidson, Peter J. ; Garfein, Richard S. ; Smith, Laramie R. ; Pitpitan, Eileen V. ; Goldenberg, Shira M. ; Strathdee, Steffanie A.</creatorcontrib><description>Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. PWID were recruited via street outreach for a longitudinal cohort study from October 2020–September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE score levels (low, medium, high) using ordinal logistic regression. Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to change the risk environment.</description><identifier>ISSN: 1090-7165</identifier><identifier>ISSN: 1573-3254</identifier><identifier>EISSN: 1573-3254</identifier><identifier>DOI: 10.1007/s10461-024-04433-9</identifier><identifier>PMID: 39060837</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; California - epidemiology ; Coinjection ; Correlation ; Disease transmission ; Drugs ; Effectiveness ; Female ; Fentanyl ; Health Psychology ; Hepatitis C - epidemiology ; HIV ; HIV Infections - epidemiology ; HIV Seropositivity - epidemiology ; Homeless people ; Homelessness ; Human immunodeficiency virus ; Humans ; Inequality ; Infectious Diseases ; Injection ; Longitudinal Studies ; Male ; Measures ; Medicine ; Medicine & Public Health ; Mexico - epidemiology ; Middle Aged ; Original Paper ; Public Health ; Residents ; Risk ; Risk behavior ; Risk taking ; Self Efficacy ; Substance Abuse, Intravenous - complications ; Substance Abuse, Intravenous - epidemiology ; Substance Abuse, Intravenous - psychology</subject><ispartof>AIDS and behavior, 2024-11, Vol.28 (11), p.3629-3642</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-fcd16b1583d24f6f7031f039a7f8d217ad4f4e43f29fdf515f5c6c213664160d3</cites><orcidid>0000-0002-7724-691X ; 0000-0003-4231-211X ; 0000-0002-4794-117X ; 0009-0001-2764-5533 ; 0000-0003-0159-0981 ; 0000-0002-8708-8169 ; 0000-0003-3663-7153 ; 0000-0003-3376-152X ; 0000-0003-1633-9749 ; 0000-0002-5371-3229 ; 0000-0002-2969-7193</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,33774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39060837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bailey, Katie</creatorcontrib><creatorcontrib>Abramovitz, Daniela</creatorcontrib><creatorcontrib>Rangel, Gudelia</creatorcontrib><creatorcontrib>Harvey-Vera, Alicia</creatorcontrib><creatorcontrib>Vera, Carlos F.</creatorcontrib><creatorcontrib>Patterson, Thomas L.</creatorcontrib><creatorcontrib>Sánchez-Lira, Jaime Arredondo</creatorcontrib><creatorcontrib>Davidson, Peter J.</creatorcontrib><creatorcontrib>Garfein, Richard S.</creatorcontrib><creatorcontrib>Smith, Laramie R.</creatorcontrib><creatorcontrib>Pitpitan, Eileen V.</creatorcontrib><creatorcontrib>Goldenberg, Shira M.</creatorcontrib><creatorcontrib>Strathdee, Steffanie A.</creatorcontrib><title>Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region</title><title>AIDS and behavior</title><addtitle>AIDS Behav</addtitle><addtitle>AIDS Behav</addtitle><description>Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. PWID were recruited via street outreach for a longitudinal cohort study from October 2020–September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE score levels (low, medium, high) using ordinal logistic regression. Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to change the risk environment.</description><subject>Adult</subject><subject>California - epidemiology</subject><subject>Coinjection</subject><subject>Correlation</subject><subject>Disease transmission</subject><subject>Drugs</subject><subject>Effectiveness</subject><subject>Female</subject><subject>Fentanyl</subject><subject>Health Psychology</subject><subject>Hepatitis C - epidemiology</subject><subject>HIV</subject><subject>HIV Infections - epidemiology</subject><subject>HIV Seropositivity - epidemiology</subject><subject>Homeless people</subject><subject>Homelessness</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Inequality</subject><subject>Infectious Diseases</subject><subject>Injection</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Measures</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mexico - epidemiology</subject><subject>Middle Aged</subject><subject>Original Paper</subject><subject>Public Health</subject><subject>Residents</subject><subject>Risk</subject><subject>Risk behavior</subject><subject>Risk taking</subject><subject>Self Efficacy</subject><subject>Substance Abuse, Intravenous - complications</subject><subject>Substance Abuse, Intravenous - epidemiology</subject><subject>Substance Abuse, Intravenous - psychology</subject><issn>1090-7165</issn><issn>1573-3254</issn><issn>1573-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>BHHNA</sourceid><recordid>eNp9kUuOEzEQhi0EYobABVggS2zYNJTbj-5ehsxAIo0EIsOwtDx-dBx17GB3g7LjCogbchIMCSCxYOWS_NVfpfoQekzgOQFoXmQCTJAKalYBY5RW3R10TnhDK1pzdrfU0EHVEMHP0IOctwDQiaa7j85oBwJa2pyjr2vlLF6FrdWjjwGv7eCqS-e8VvqAfcbznKP2arQGf_bjBi8XN1gFg5ermwKnuI_Zj_6THw94vouhx29t3A8Wf9jEUyy-SFOfsQ943Fi8VgFfeNvH71--XfvtpILCL2MyNuF3ti8rPET3nBqyfXR6Z-j9q8vrxbK6evN6tZhfVbrmYqycNkTcEt5SUzMnXAOUOKCdalxratIowxyzjLq6c8Zxwh3XQteECsGIAENn6Nkxd5_ix8nmUe581nYYVLBxypJCywkRpFx2hp7-g27jlELZTtKCgKC8awtVHymdYs7JOrlPfqfSQRKQP4XJozBZhMlfwmRXmp6coqfbnTV_Wn4bKgA9Arl8hd6mv7P_E_sDk_agyQ</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>Bailey, Katie</creator><creator>Abramovitz, Daniela</creator><creator>Rangel, Gudelia</creator><creator>Harvey-Vera, Alicia</creator><creator>Vera, Carlos F.</creator><creator>Patterson, Thomas L.</creator><creator>Sánchez-Lira, Jaime Arredondo</creator><creator>Davidson, Peter J.</creator><creator>Garfein, Richard S.</creator><creator>Smith, Laramie R.</creator><creator>Pitpitan, Eileen V.</creator><creator>Goldenberg, Shira M.</creator><creator>Strathdee, Steffanie A.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U3</scope><scope>7U9</scope><scope>BHHNA</scope><scope>C1K</scope><scope>H94</scope><scope>K7.</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7724-691X</orcidid><orcidid>https://orcid.org/0000-0003-4231-211X</orcidid><orcidid>https://orcid.org/0000-0002-4794-117X</orcidid><orcidid>https://orcid.org/0009-0001-2764-5533</orcidid><orcidid>https://orcid.org/0000-0003-0159-0981</orcidid><orcidid>https://orcid.org/0000-0002-8708-8169</orcidid><orcidid>https://orcid.org/0000-0003-3663-7153</orcidid><orcidid>https://orcid.org/0000-0003-3376-152X</orcidid><orcidid>https://orcid.org/0000-0003-1633-9749</orcidid><orcidid>https://orcid.org/0000-0002-5371-3229</orcidid><orcidid>https://orcid.org/0000-0002-2969-7193</orcidid></search><sort><creationdate>20241101</creationdate><title>Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region</title><author>Bailey, Katie ; Abramovitz, Daniela ; Rangel, Gudelia ; Harvey-Vera, Alicia ; Vera, Carlos F. ; Patterson, Thomas L. ; Sánchez-Lira, Jaime Arredondo ; Davidson, Peter J. ; Garfein, Richard S. ; Smith, Laramie R. ; Pitpitan, Eileen V. ; Goldenberg, Shira M. ; Strathdee, Steffanie A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-fcd16b1583d24f6f7031f039a7f8d217ad4f4e43f29fdf515f5c6c213664160d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>California - epidemiology</topic><topic>Coinjection</topic><topic>Correlation</topic><topic>Disease transmission</topic><topic>Drugs</topic><topic>Effectiveness</topic><topic>Female</topic><topic>Fentanyl</topic><topic>Health Psychology</topic><topic>Hepatitis C - epidemiology</topic><topic>HIV</topic><topic>HIV Infections - epidemiology</topic><topic>HIV Seropositivity - epidemiology</topic><topic>Homeless people</topic><topic>Homelessness</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Inequality</topic><topic>Infectious Diseases</topic><topic>Injection</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Measures</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mexico - epidemiology</topic><topic>Middle Aged</topic><topic>Original Paper</topic><topic>Public Health</topic><topic>Residents</topic><topic>Risk</topic><topic>Risk behavior</topic><topic>Risk taking</topic><topic>Self Efficacy</topic><topic>Substance Abuse, Intravenous - complications</topic><topic>Substance Abuse, Intravenous - epidemiology</topic><topic>Substance Abuse, Intravenous - psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bailey, Katie</creatorcontrib><creatorcontrib>Abramovitz, Daniela</creatorcontrib><creatorcontrib>Rangel, Gudelia</creatorcontrib><creatorcontrib>Harvey-Vera, Alicia</creatorcontrib><creatorcontrib>Vera, Carlos F.</creatorcontrib><creatorcontrib>Patterson, Thomas L.</creatorcontrib><creatorcontrib>Sánchez-Lira, Jaime Arredondo</creatorcontrib><creatorcontrib>Davidson, Peter J.</creatorcontrib><creatorcontrib>Garfein, Richard S.</creatorcontrib><creatorcontrib>Smith, Laramie R.</creatorcontrib><creatorcontrib>Pitpitan, Eileen V.</creatorcontrib><creatorcontrib>Goldenberg, Shira M.</creatorcontrib><creatorcontrib>Strathdee, Steffanie A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Social Services Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Sociological Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>AIDS and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bailey, Katie</au><au>Abramovitz, Daniela</au><au>Rangel, Gudelia</au><au>Harvey-Vera, Alicia</au><au>Vera, Carlos F.</au><au>Patterson, Thomas L.</au><au>Sánchez-Lira, Jaime Arredondo</au><au>Davidson, Peter J.</au><au>Garfein, Richard S.</au><au>Smith, Laramie R.</au><au>Pitpitan, Eileen V.</au><au>Goldenberg, Shira M.</au><au>Strathdee, Steffanie A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region</atitle><jtitle>AIDS and behavior</jtitle><stitle>AIDS Behav</stitle><addtitle>AIDS Behav</addtitle><date>2024-11-01</date><risdate>2024</risdate><volume>28</volume><issue>11</issue><spage>3629</spage><epage>3642</epage><pages>3629-3642</pages><issn>1090-7165</issn><issn>1573-3254</issn><eissn>1573-3254</eissn><abstract>Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. PWID were recruited via street outreach for a longitudinal cohort study from October 2020–September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE score levels (low, medium, high) using ordinal logistic regression. Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to change the risk environment.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>39060837</pmid><doi>10.1007/s10461-024-04433-9</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-7724-691X</orcidid><orcidid>https://orcid.org/0000-0003-4231-211X</orcidid><orcidid>https://orcid.org/0000-0002-4794-117X</orcidid><orcidid>https://orcid.org/0009-0001-2764-5533</orcidid><orcidid>https://orcid.org/0000-0003-0159-0981</orcidid><orcidid>https://orcid.org/0000-0002-8708-8169</orcidid><orcidid>https://orcid.org/0000-0003-3663-7153</orcidid><orcidid>https://orcid.org/0000-0003-3376-152X</orcidid><orcidid>https://orcid.org/0000-0003-1633-9749</orcidid><orcidid>https://orcid.org/0000-0002-5371-3229</orcidid><orcidid>https://orcid.org/0000-0002-2969-7193</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1090-7165 |
ispartof | AIDS and behavior, 2024-11, Vol.28 (11), p.3629-3642 |
issn | 1090-7165 1573-3254 1573-3254 |
language | eng |
recordid | cdi_proquest_miscellaneous_3085116144 |
source | Springer Nature; Sociological Abstracts |
subjects | Adult California - epidemiology Coinjection Correlation Disease transmission Drugs Effectiveness Female Fentanyl Health Psychology Hepatitis C - epidemiology HIV HIV Infections - epidemiology HIV Seropositivity - epidemiology Homeless people Homelessness Human immunodeficiency virus Humans Inequality Infectious Diseases Injection Longitudinal Studies Male Measures Medicine Medicine & Public Health Mexico - epidemiology Middle Aged Original Paper Public Health Residents Risk Risk behavior Risk taking Self Efficacy Substance Abuse, Intravenous - complications Substance Abuse, Intravenous - epidemiology Substance Abuse, Intravenous - psychology |
title | Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A09%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safe%20Injection%20Self-Efficacy%20is%20Associated%20with%20HCV%20and%20HIV%20Seropositivity%20Among%20People%20Who%20Inject%20Drugs%20in%20the%20San%20Diego%E2%80%93Tijuana%20Border%20Region&rft.jtitle=AIDS%20and%20behavior&rft.au=Bailey,%20Katie&rft.date=2024-11-01&rft.volume=28&rft.issue=11&rft.spage=3629&rft.epage=3642&rft.pages=3629-3642&rft.issn=1090-7165&rft.eissn=1573-3254&rft_id=info:doi/10.1007/s10461-024-04433-9&rft_dat=%3Cproquest_cross%3E3085116144%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c256t-fcd16b1583d24f6f7031f039a7f8d217ad4f4e43f29fdf515f5c6c213664160d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3116063598&rft_id=info:pmid/39060837&rfr_iscdi=true |